Tuesday, December 31, 2019

Indoco gets USFDA nod for Febuxostat tablets

Indoco gets USFDA nod for Febuxostat tablets "Indoco Remedies received final approval of its ANDA (Abbreviated New Drug Application) for Febuxostat tablets 40 mg and 80 mg, which is therapeutically equivalent to the Reference Listed Drug (RLD), viz, Uloric Tablets 40 mg and 80 mg of Takeda Pharmaceuticals USA, Inc," the company said in a filing to the BSE.

from Moneycontrol Business News https://ift.tt/2tmoKe3
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Weekly Expiry: Sensex mirrors Nifty's swings, but with milder spurts

The recent weekly expiry of Sensex showcased unexpected surges in the index and heightened options premiums. Traders observe that such fluct...